Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Roman Shingarev"'
Autor:
Mariana Murea, Ali I. Gardezi, Mathew P. Goldman, Caitlin W. Hicks, Timmy Lee, John P. Middleton, Roman Shingarev, Tushar J. Vachharajani, Karen Woo, Lama M. Abdelnour, Kyla M. Bennett, Duvuru Geetha, Lee Kirksey, Kevin W Southerland, Carlton J. Young, William M. Brown, Judy Bahnson, Haiying Chen, Michael Allon
Publikováno v:
BMC Nephrology, Vol 24, Iss 1, Pp 1-14 (2023)
Abstract Background Treatment of end-stage kidney disease (ESKD) with hemodialysis requires surgical creation of an arteriovenous (AV) vascular access—fistula (AVF) or graft (AVG)—to avoid (or limit) the use of a central venous catheter (CVC). AV
Externí odkaz:
https://doaj.org/article/43d867c7935a421cb56628033773999b
Autor:
Barak Rosenzweig, Nimrod D Rubinstein, Ed Reznik, Roman Shingarev, Krishna Juluru, Oguz Akin, James J Hsieh, Edgar A Jaimes, Paul Russo, Katalin Susztak, Jonathan A Coleman, A Ari Hakimi
Publikováno v:
PLoS ONE, Vol 12, Iss 7, p e0180350 (2017)
BACKGROUND AND OBJECTIVES:Pre-operative kidney volume is an independent predictor of glomerular filtration rate in renal cell carcinoma patients. Compensatory renal growth (CRG) can ensue prior to nephrectomy in parallel to tumor growth and benign pa
Externí odkaz:
https://doaj.org/article/4c4d796e7e0e46ddaa48bf45438d38f9
Publikováno v:
Kidney360
BACKGROUND: Long-term arteriovenous fistula (AVF) survival has been shown to be adversely affected by the presence of previous tunneled vascular catheters (TVC). We analyzed the effect of previous TVCs and their location (ipsilateral versus contralat
Autor:
Mohamed Hassanein, Yeshwanter Radhakrishnan, Nora Hernandez Garcilazo, Si Yuan Khor, Sayna Norouzi, Evamaria Anvari, Roman Shingarev, Tushar J Vachharajani
Publikováno v:
The Journal of Vascular Access. :112972982311592
The development of vascular access for hemodialysis has come a long way since 1943 when the first hemodialysis treatment was performed in humans by connecting an artery and vein using an external glass canula. Since then, vascular access care has evo
Autor:
Jennifer Heinen, Ashley E. Russo, Edgar A. Jaimes, Meier Hsu, Roman Shingarev, Luke V. Selby, Garrett M. Nash
Publikováno v:
Clinical Nephrology. 94:281-289
Background Contrast-induced nephropathy is a well-recognized acute complication in cancer patients, but the long-term effects of repeated contrast exposure are not known. We analyzed the association of the number of contrast-enhanced computed tomogra
Autor:
Matthew Abramson, Roman Shingarev
Publikováno v:
Journal of Onco-Nephrology. 4:28-36
Hematopoietic cell transplantation is an important therapeutic option for many hematologic cancers. Kidney injury after hematopoietic cell transplantation often results from exposure to chemotherapy and radiation therapy, antibiotics, immunosuppressa
Autor:
Alexander S. Yevzlin, Roman Shingarev
Publikováno v:
Interventional Nephrology ISBN: 9783030811549
Interventional Nephrology ISBN: 9781461488026
Interventional Nephrology ISBN: 9781461488026
Despite substantial efforts by nephrology community to reduce utilization of dialysis catheters, majority of end-stage renal disease patients in the USA initiate hemodialysis (HD) with a tunneled dialysis catheter (TDC) with approximately one-quarter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f297dabe4369f595bef04a639afcd82a
https://doi.org/10.1007/978-3-030-81155-6_9
https://doi.org/10.1007/978-3-030-81155-6_9
Autor:
Jonathan A. Coleman, Nicholas Power, A. Ari Hakimi, Nathan C. Wong, Katie S. Murray, Massimiliano Spaliviero, Ricardo Alvim, Daniel Sjöberg, Paul Russo, Nicole Benfante, Roman Shingarev
Publikováno v:
Eur Urol Focus
Our recently reported phase III trial demonstrated that patients undergoing nephron-sparing surgery (NSS) with an estimated glomerular filtration rate (eGFR) of ≥45 ml/min/1.73 m2 who received mannitol had no improvement in renal function at 6 mo c
Autor:
Roman Shingarev, Ilya G. Glezerman
Publikováno v:
Am J Kidney Dis
Immunologic control of malignancy has long been recognized as an important determinant of disease progression. Recent advances in immunology have led to the focus on several mechanisms that can be targeted to achieve tumor suppression. In particular,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a27feb36514c34c76902eb7b722614a5
https://europepmc.org/articles/PMC6756976/
https://europepmc.org/articles/PMC6756976/
Autor:
A. Ari Hakimi, Nicole Benfante, Nathan C. Wong, Katie S. Murray, Maximillian Spaliviero, Daniel Sjöberg, Roman Shingarev, Jonathan A. Coleman, Ricardo Alvim, Paul Russo, Nicholas Power
Publikováno v:
Journal of Urology. 201